Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs

被引:2
作者
Shahverdi, Mahshid [1 ]
Alamdari-Palangi, Vahab [2 ]
Alipour, Shiva [3 ,4 ]
Jolfayi, Amir Ghaffari [5 ]
Masoumi, Javad [3 ]
Aghebati-Maleki, Leili [3 ]
Rostamlou, Arman [6 ]
Baradaran, Behzad [3 ]
机构
[1] Arak Univ Med Sci, Dept Med Biotechnol, Arak, Iran
[2] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Mol Med, Shiraz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[5] Iran Univ Med Sci, Cardiovasc Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
[6] Univ EGE, Fac Med, Dept Med Biol, Izmir, Turkiye
关键词
Dendritic cell; delivery systems; immunotherapy; small interfering RNA; targeted immunomodulation; genes' expression; SIRNA DELIVERY; TUMOR-ANTIGEN; VACCINE POTENCY; T-CELLS; POLYMERIC MICELLES; CANCER; GENE; INDUCTION; INTERLEUKIN-10; RECEPTOR;
D O I
10.2174/0115665240303370240530120450
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gene silencing through RNA interference (RNAi) technology has provided forceful therapeutic modalities to specific knockdown of the genes' expression related to diseases. Small interfering RNAs (siRNAs) can start a process that specifically degrades and silences the expression of cognate mRNAs. These RNA interference processes could effectively adjust many biological processes, including immune responses. Dendritic cells (DCs) are specialist antigen-presenting cells with potent functions in regulating innate and adaptive immunity. SiRNAs performed vital roles in coordinating immune processes mediated by DCs. This review describes the findings that shed light on the significance of siRNAs in DC immune regulation and highlight their potential applications for improving DC-based immunotherapies
引用
收藏
页数:18
相关论文
共 183 条
  • [71] Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
    Kobayashi, Hisataka
    Watanabe, Rira
    Choyke, Peter L.
    [J]. THERANOSTICS, 2014, 4 (01): : 81 - 89
  • [72] A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma
    Koch, Elias A. T.
    Schaft, Niels
    Kummer, Mirko
    Berking, Carola
    Schuler, Gerold
    Hasumi, Kenichiro
    Doerrie, Jan
    Schuler-Thurner, Beatrice
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [73] Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
    Koren, Michael J.
    Moriarty, Patrick Maurice
    Baum, Seth J.
    Neutel, Joel
    Hernandez-Illas, Martha
    Weintraub, Howard S.
    Florio, Monica
    Kassahun, Helina
    Melquist, Stacey
    Varrieur, Tracy
    Haldar, Saptarsi M.
    Sohn, Winnie
    Wang, Huei
    Elliott-Davey, Mary
    Rock, Brooke M.
    Pei, Tao
    Homann, Oliver
    Hellawell, Jennifer
    Watts, Gerald F.
    [J]. NATURE MEDICINE, 2022, 28 (01) : 96 - +
  • [74] Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
    Kulkarni, Jayesh A.
    Witzigmann, Dominik
    Chen, Sam
    Cullis, Pieter R.
    van der Meel, Roy
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (09) : 2435 - 2444
  • [75] Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells
    Kurtulus, Sema
    Madi, Asaf
    Escobar, Giulia
    Klapholz, Max
    Nyman, Jackson
    Christian, Elena
    Pawlak, Mathias
    Dionne, Danielle
    Xia, Junrong
    Rozenblatt-Rosen, Orit
    Kuchroo, Vijay K.
    Regev, Aviv
    Anderson, Ana C.
    [J]. IMMUNITY, 2019, 50 (01) : 181 - +
  • [76] Induction of the glucocorticoid-induced leucine zipper gene limits the efficacy of dendritic cell vaccines
    Lebson, L.
    Wang, T.
    Jiang, Q.
    Whartenby, K. A.
    [J]. CANCER GENE THERAPY, 2011, 18 (08) : 563 - 570
  • [77] Dendritic cells with increased expression of suppressor of cytokine signaling 1(SOCS1) gene ameliorate lipopolysaccharide/D-galactosamine-induced acute liver failure
    Li, Shan-Shan
    Yang, Min
    Chen, Yong-Ping
    Tang, Xin-Yue
    Zhang, Sheng-Guo
    Ni, Shun-Lan
    Yang, Nai-Bin
    Lu, Ming-Qin
    [J]. MOLECULAR IMMUNOLOGY, 2018, 101 : 10 - 18
  • [78] Effects of SOCS1-overexpressing dendritic cells on Th17-and Treg-related cytokines in COPD mice
    Liao, Shi-xia
    Chen, Jie
    Zhang, Lan-Ying
    Zhang, Jing
    Sun, Peng-Peng
    Ou-Yang, Yao
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [79] Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model
    Liu, Yanling
    Xu, Ping
    Liu, Huan
    Fang, Chunjuan
    Guo, Haihe
    Chen, Xiaoyan
    Tan, Manman
    Zhang, Yujuan
    Min, Weiping
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (02) : 587 - 597
  • [80] Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia
    Locatelli, Franco
    Thompson, Alexis A.
    Kwiatkowski, Janet L.
    Porter, John B.
    Thrasher, Adrian J.
    Hongeng, Suradej
    Sauer, Martin G.
    Thuret, Isabelle
    Lal, Ashutosh
    Algeri, Mattia
    Schneiderman, Jennifer
    Olson, Timothy S.
    Carpenter, Ben
    Amrolia, Persis J.
    Anurathapan, Usanarat
    Schambach, Axel
    Chabannon, Christian
    Schmidt, Manfred
    Labik, Ivan
    Elliot, Heidi
    Guo, Ruiting
    Asmal, Mohammed
    Colvin, Richard A.
    Walters, Mark C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) : 415 - 427